ANSTO to manufacture new radiopharmaceutical at Lucas Heights
The Australian Nuclear Science and Technology Organisation (ANSTO) and medical device company OncoBeta GmbH are to partner to manufacture a new radioisotope at Lucas Heights in New South Wales for the treatment of non-melanoma skin cancers (NMSCs). They have signed a Letter of Intent to establish manufacturing and distribution in Australia for OncoBeta’s novel Rhenium-SCT…
Details